HCAR3 and metabolic syndrome: HCAR2 shares the highest sequence similarity with HCAR3 in HCAR family, and is considered to be a molecular target for regulating dyslipidemia, activated by the endogenous ligand 3-hydroxybutyric acid [12,13].